A Phase 2b, Randomized, Double-Blind, Multi-center Study Comparing Cross-linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects
This is a placebo-controlled study to determine the effect of CLP in heart failure subjects with fluid overload.
A Phase 1, Open-label, Randomized, Crossover Study to Assess the Safety, Tolerability, and Efficacy of CLP With and Without Spironolactone in Adults With Heart Failure
The purpose of this study is to determine the effects of CLP, with and without spironolactone, on serum, urine, and fecal contents in heart failure patients with chronic kidney disease.
A Phase 2, Randomized, Double-Blind, Multi-center Study Comparing CLP Versus Placebo in Heart Failure Patients With Chronic Kidney Disease
The purpose of this study is to determine the effects of CLP on serum potassium and signs and symptoms of fluid overload in heart failure patients with chronic kidney disease.
100 Clinical Results associated with Sorbent Therapeutics, Inc.
0 Patents (Medical) associated with Sorbent Therapeutics, Inc.
01 Jan 2007·Contributions to nephrology
The Birth of Hemodiafiltration
Review
Author: Henderson, L W
100 Deals associated with Sorbent Therapeutics, Inc.
100 Translational Medicine associated with Sorbent Therapeutics, Inc.